Projections of the future burden of COPD in the Netherlands by disease severity using a dynamic population model of disease progression Source: Eur Respir J 2004; 24: Suppl. 48, 700s Year: 2004
Hyaluronic acid as a novel systemic biomarker to predict progression and severity in chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016
Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008
Is there any relationship between the duration to diagnosis of COPD and severity of the disease? Source: Annual Congress 2012 - Diagnostic insights and decision making in primary care Year: 2012
Development of a predictive model for chronic obstructive pulmonary disease onset with identification and ranking of risk factors Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021
A clinical scoring algorithm to predict all cause mortality in COPD Source: Annual Congress 2007 - Clinical aspects in COPD Year: 2007
COPD exacerbations: definitions and classifications Source: Eur Respir J 2003; 21: 46S-53S Year: 2003
Agreement of severity stages and exacerbations building the new COPD risk groups Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation Year: 2013
Development of a decision tree to assess the severity and prognosis of stable COPD Source: Eur Respir J 2011; 38: 1294-1300 Year: 2011
Subphenotyping COPD: is it relevant for therapeutic intervention and disease outcome? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005
Are COPD exacerbations associated with the severity of the disease? Source: Eur Respir J 2005; 26: Suppl. 49, 300s Year: 2005
Need for generalized criteria in evaluating the impact of new drugs in clinical trials involving patients suffering from COPD Source: Annual Congress 2006 - Outcomes for COPD pharmacological trials: from lung function to biomarkers Year: 2006
Does the 2011 GOLD staging of COPD reflect phenotype and severity of the disease as assessed by CT? Source: Annual Congress 2013 –COPD treatment and others Year: 2013
Relationship between pharmacotherapy and severity of disease in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 73s Year: 2007
An audio-imaging approach to measure the degree of severity of patients suffering from DPLD disease Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment Year: 2018
The relationship between depression, medication and stage of the disease in patients with COPD Source: Annual Congress 2006 - COPD comorbidity Year: 2006
Cough rate may predict disease severity in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 536s Year: 2004
Application of omics technologies to the identification of biomarkers for COPD Source: Annual Congress 2007 - Cell biology of asthma and COPD Year: 2007
OdyseiBG – systematic approach for complex assessment and staging of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 243s Year: 2003
Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007